---
title: "XTL Biopharma (XTLB.US) Soars 63% After Psyga Bio Deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284601388.md"
description: "XTL 生物制药（XTLB.US）现价 $3.750，当日 +63.04%，盘中涨幅显著，市值 0.09 亿。公司主营生物医药，盘中大涨受收购 Psyga Bio 消息推动。此项全股票交易提升公司管线资产，市场期待其后续产品开发进度。"
datetime: "2026-04-29T15:01:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284601388.md)
  - [en](https://longbridge.com/en/news/284601388.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284601388.md)
generator: "portal-rs"
---

# XTL Biopharma (XTLB.US) Soars 63% After Psyga Bio Deal

XTL Biopharmaceuticals (XTLB.US) trades at $3.750, up **+63.04%** intraday, with significant gains. Market cap stands at $9 million.

Operating in biopharmaceuticals, shares surged following news of an all-share acquisition of Psyga Bio. The deal strengthens the company’s pipeline assets, and investors are watching for upcoming product development milestones.

### Related Stocks

- [XTLB.US](https://longbridge.com/en/quote/XTLB.US.md)

## Related News & Research

- [BREAKINGVIEWS-Netflix morphs into same couch potato it smashed](https://longbridge.com/en/news/302451031.md)
- [Micron Stock Moves Higher: What's Going On?](https://longbridge.com/en/news/302449704.md)
- [INSIGHT-Volkswagen bet on Xpeng to save its China business. It's not going to plan](https://longbridge.com/en/news/302363252.md)
- [Morgan Stanley's Mike Wilson Says Market Correction Nearly Over, Sees S&P 500 Hitting 8,500](https://longbridge.com/en/news/302450465.md)
- [Blue Zone Wealth Advisors LLC Makes New Investment in Marvell Technology, Inc. $MRVL](https://longbridge.com/en/news/302376042.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**